index,Regulator Name,Regulator Type,Regulator Subtype,Regulator HGNC Symbol,Regulator Database,Regulator ID,Regulator Compartment,Regulator Compartment ID,Regulated Name,Regulated Type,Regulated Subtype,Regulated HGNC Symbol,Regulated Database,Regulated ID,Regulated Compartment,Regulated Compartment ID,Sign,Connection Type,Mechanism,Site,Cell Line,Cell Type,Tissue Type,Organism,Score,Source,Statements,Paper IDs,Evidence Score,Match Score,Kind Score,Epistemic Value,Total Score
4,braf,protein,,braf,hgnc,1097,,,tert,protein,,tert,hgnc,11730,,,positive,i,increaseamount,,,,,,0.65,nan,"the acquisition of tert promoter mutation in braf or nras mutated melanoma probably allows the re-expression of tert leading to the immortalization process on path to melanoma development, together with other alterations such as inactivation of cyclin dependent kinase inhibitor 2a (cdkn2a).",pmc5288173,1,10,5,1,15
14,mtor,protein,,mtor,hgnc,3942,,,braf,protein,,braf,hgnc,1097,,,negative,i,inhibition,,,,,,0.65,nan,"xref_bibr, xref_bibr another preclinical study demonstrated that the combination of selumetinib and a mammalian target of rapamycin (mtor) inhibitor (azd8055) which is downstream of pi3k and akt pathway, induces tumor regression in braf mutant uveal melanoma cell lines but not gnaq mutant cell lines.",pmc4179759,1,10,5,1,15
